CN114317417B - Method for inducing skeletal muscle satellite cells to generate lipid droplets - Google Patents
Method for inducing skeletal muscle satellite cells to generate lipid droplets Download PDFInfo
- Publication number
- CN114317417B CN114317417B CN202011076142.8A CN202011076142A CN114317417B CN 114317417 B CN114317417 B CN 114317417B CN 202011076142 A CN202011076142 A CN 202011076142A CN 114317417 B CN114317417 B CN 114317417B
- Authority
- CN
- China
- Prior art keywords
- skeletal muscle
- basal medium
- insulin
- satellite cells
- muscle satellite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000419 skeletal muscle satellite cell Anatomy 0.000 title claims abstract description 25
- 238000000034 method Methods 0.000 title claims abstract description 22
- 150000002632 lipids Chemical class 0.000 title claims abstract description 10
- 230000001939 inductive effect Effects 0.000 title claims abstract description 7
- 210000003205 muscle Anatomy 0.000 claims abstract description 7
- 230000004132 lipogenesis Effects 0.000 claims abstract description 4
- 210000001142 back Anatomy 0.000 claims abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 42
- 239000007640 basal medium Substances 0.000 claims description 24
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims description 22
- 102000004877 Insulin Human genes 0.000 claims description 21
- 108090001061 Insulin Proteins 0.000 claims description 21
- 229940125396 insulin Drugs 0.000 claims description 21
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 11
- 229960003957 dexamethasone Drugs 0.000 claims description 11
- 229960004586 rosiglitazone Drugs 0.000 claims description 11
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 10
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 claims description 8
- 230000006698 induction Effects 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000011759 adipose tissue development Effects 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 5
- 210000004027 cell Anatomy 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 235000015277 pork Nutrition 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract 1
- 238000010186 staining Methods 0.000 description 19
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 17
- 101100351033 Mus musculus Pax7 gene Proteins 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 3
- 210000002027 skeletal muscle Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000012757 fluorescence staining Methods 0.000 description 2
- 230000003520 lipogenic effect Effects 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100298998 Caenorhabditis elegans pbs-3 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000012981 Hank's balanced salt solution Substances 0.000 description 1
- -1 IBMX Chemical compound 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000002293 adipogenic effect Effects 0.000 description 1
- 230000037037 animal physiology Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 210000000518 sarcolemma Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明属于细胞技术领域,具体涉及一种诱导骨骼肌卫星细胞生成脂滴的方法。The invention belongs to the field of cell technology, and in particular relates to a method for inducing skeletal muscle satellite cells to generate lipid droplets.
背景技术Background technique
肉类生产是畜牧业的重要组成部分,随着生活水平的不断提高,肉品的需求量与日俱增,如何提高肉类生产水平已成为科技工作者的重要任务(“骨骼肌分泌对猪肌肉生长代谢的调节”,陈杰,全国动物生理生化第十次学术交流会论文摘要汇编,2008年,第10页摘要第1-2行,公开日2009年6月10日)。Meat production is an important part of animal husbandry. With the continuous improvement of living standards, the demand for meat products is increasing day by day. How to improve the level of meat production has become an important task for scientific and technological workers ("Skeletal muscle secretion affects pig muscle growth and metabolism Regulation", Chen Jie, Compilation of Abstracts of the Tenth National Symposium on Animal Physiology and Biochemistry, 2008, page 10, line 1-2 of the abstract, open date June 10, 2009).
然而,现有的猪的肉质品质不佳。However, the meat quality of existing pigs is not good.
发明内容Contents of the invention
有鉴于此,本发明的目的在于提供一种诱导骨骼肌卫星细胞生成脂滴的方法。In view of this, the purpose of the present invention is to provide a method for inducing skeletal muscle satellite cells to generate lipid droplets.
为实现上述目的,本发明的技术方案为:To achieve the above object, the technical solution of the present invention is:
诱导骨骼肌卫星细胞生成脂滴的方法,包括以下步骤:A method for inducing skeletal muscle satellite cells to generate lipid droplets, comprising the following steps:
从刚出生1-5d的仔猪背肌中采集骨骼肌卫星细胞,并纯化,纯化后的骨骼肌卫星细胞待贴壁汇合到60%-70%时,进行生脂诱导。Skeletal muscle satellite cells were collected from the dorsal muscle of newborn 1-5d piglets, and purified. When the purified skeletal muscle satellite cells reached 60%-70% confluence, adipogenic induction was performed.
进一步,所述纯化采用差速贴壁方法。Further, the purification adopts a differential attachment method.
进一步,所述生脂诱导包括以下步骤:Further, the lipogenesis induction comprises the following steps:
第1-2d,向基础培养基中添加地塞米松、胰岛素、3-异丁基-1-甲基黄嘌呤和双抗,培养2d;On the 1st-2d, add dexamethasone, insulin, 3-isobutyl-1-methylxanthine and double antibody to the basal medium, and culture for 2d;
第3-4d,向基础培养基中添加胰岛素、罗格列酮和双抗,培养2d;On the 3rd-4th day, add insulin, rosiglitazone and double antibodies to the basal medium, and culture for 2 days;
第5-6d,向基础培养基中添加地塞米松、胰岛素、3-异丁基-1-甲基黄嘌呤和双抗,培养2d;On the 5th-6th day, add dexamethasone, insulin, 3-isobutyl-1-methylxanthine and double antibody to the basal medium, and culture for 2 days;
第7-8d,向基础培养基中添加胰岛素、罗格列酮和双抗,培养2d;On the 7th-8th day, add insulin, rosiglitazone and double antibodies to the basal medium, and culture for 2 days;
第9-10d,基础培养基中添加葡萄糖和双抗,培养2d。On the 9th-10th day, glucose and double antibodies were added to the basal medium, and cultured for 2 days.
进一步,所述基础培养基采用DMEM/F12培养基。Further, the basal medium adopts DMEM/F12 medium.
进一步,第1-2d,向基础培养基中添加0.5-1μmol/L地塞米松、5-10μg/mL胰岛素、0.1-0.5mmol/L 3-异丁基-1-甲基黄嘌呤和1%-1.5%双抗,培养2d,所述百分比为体积百分比。Further, on day 1-2, add 0.5-1 μmol/L dexamethasone, 5-10 μg/mL insulin, 0.1-0.5 mmol/L 3-isobutyl-1-methylxanthine and 1% -1.5% double antibody, cultivated for 2 days, the percentage is volume percentage.
进一步,第3-4d,向基础培养基中添加5-10μg/mL胰岛素、5-10uM罗格列酮和1%-1.5%双抗,培养2d,所述百分比为体积百分比。Further, on the 3rd to 4th day, add 5-10 μg/mL insulin, 5-10 uM rosiglitazone and 1%-1.5% double antibody to the basal medium, culture for 2 days, and the percentages are volume percentages.
进一步,第5-6d,向基础培养基中添加0.5-1μmol/L地塞米松、5-10μg/mL胰岛素、0.1-0.5mmol/L 3-异丁基-1-甲基黄嘌呤和1%-1.5%双抗,培养2d,所述百分比为体积百分比。Further, on the 5th-6th day, add 0.5-1 μmol/L dexamethasone, 5-10 μg/mL insulin, 0.1-0.5 mmol/L 3-isobutyl-1-methylxanthine and 1% -1.5% double antibody, cultivated for 2 days, the percentage is volume percentage.
进一步,第7-8d,向基础培养基中添加5-10μg/mL胰岛素、5-10uM罗格列酮和1%-1.5%双抗,培养2d,所述百分比为体积百分比。Further, on the 7th-8th day, 5-10 μg/mL insulin, 5-10 uM rosiglitazone and 1%-1.5% double antibody were added to the basal medium, and cultured for 2 days, the percentages are volume percentages.
进一步,第9-10d,向基础培养基中添加5-10mM葡萄糖和1%-1.5%双抗,培养2d,所述百分比为体积百分比。Further, on the 9th-10th day, add 5-10 mM glucose and 1%-1.5% double antibody to the basal medium, and culture for 2 days, and the percentages are volume percentages.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明的方法能够有效地诱导猪骨骼肌卫星细胞生成脂滴。The method of the invention can effectively induce pig skeletal muscle satellite cells to generate lipid droplets.
采用本发明的方法,猪骨骼肌卫星细胞生脂效果明显,从而能够有效提高猪肉质品质。By adopting the method of the invention, the satellite cells of the porcine skeletal muscle have an obvious lipogenic effect, thereby effectively improving the pork quality.
本发明的方法简单,操作便捷。The method of the invention is simple and convenient to operate.
附图说明Description of drawings
图1为实施例1得到的纯的骨骼肌卫星细胞的形态;Fig. 1 is the morphology of the pure skeletal muscle satellite cell that embodiment 1 obtains;
图2为实施例2的PAX-7荧光染色图和细胞核染色图,其中2A和2B分别为荧光染色图(*10)和细胞核染色图(*10);Fig. 2 is the PAX-7 fluorescence staining figure and cell nucleus staining figure of embodiment 2, wherein 2A and 2B are fluorescence staining figure (*10) and cell nucleus staining figure (*10) respectively;
图3为实施例4的油红O染色结果图;其中,3A和3B分别为2d(*10)和2d(*20) 的油红O染色结果图;Fig. 3 is the oil red O staining result figure of embodiment 4; Wherein, 3A and 3B are the oil red O staining result figure of 2d (*10) and 2d (*20) respectively;
图4为实施例4的油红O染色结果图;其中,4A和4B分别为4d(*10)和4d(*20) 的油红O染色结果图;Fig. 4 is the oil red O staining result figure of embodiment 4; Wherein, 4A and 4B are the oil red O staining result figure of 4d (*10) and 4d (*20) respectively;
图5为实施例4的油红O染色结果图;其中,5A和5B分别为6d(*10)和6d(*20) 的油红O染色结果图;Fig. 5 is the oil red O staining result figure of embodiment 4; Wherein, 5A and 5B are the oil red O staining result figure of 6d (*10) and 6d (*20) respectively;
图6为实施例4的油红O染色结果图;其中,6A和6B分别为8d(*10)和8d(*20) 的油红O染色结果图;Fig. 6 is the oil red O staining result figure of embodiment 4; Wherein, 6A and 6B are the oil red O staining result figure of 8d (*10) and 8d (*20) respectively;
图7为实施例4的油红O染色结果图;其中,7A和7B分别为10d(*10)和10d(*20) 的油红O染色结果图。Fig. 7 is the oil red O staining result figure of embodiment 4; Wherein, 7A and 7B are the oil red O staining result figure of 10d (*10) and 10d (*20) respectively.
具体实施方式Detailed ways
所举实施例是为了更好地对本发明的内容进行说明,但并不是本发明的内容仅限于所举实施例。所以熟悉本领域的技术人员根据上述发明内容对实施方案进行非本质的改进和调整,仍属于本发明的保护范围。The examples given are for better description of the content of the present invention, but the content of the present invention is not limited to the examples given. Therefore, non-essential improvements and adjustments to the implementation by those skilled in the art based on the content of the invention above still fall within the scope of protection of the present invention.
以下DMEM/F12培养基、胎牛血清FBS、L-Glutamax和Non-Essentia Amino AcidsSolution来自美国Gibco公司;The following DMEM/F12 medium, fetal bovine serum FBS, L-Glutamax and Non-Essentia Amino AcidsSolution are from Gibco, USA;
以下基础成纤维生长因子bFGF来自上海碧云天生物技术有限公司;The following basic fibroblast growth factor bFGF comes from Shanghai Biyuntian Biotechnology Co., Ltd.;
以下鸡胚提取物CEE来自美国Gemini公司;The following chicken embryo extract CEE comes from Gemini Company in the United States;
以下地塞米松、IBMX、胰岛素、罗格列酮、双抗、多聚赖氨酸、油红O、山羊抗鼠Pax7、荧光鼠源二抗和葡萄糖来自Solarbio公司。The following dexamethasone, IBMX, insulin, rosiglitazone, double antibody, polylysine, oil red O, goat anti-mouse Pax7, fluorescent mouse secondary antibody and glucose were from Solarbio.
实施例1Example 1
猪骨骼肌卫星细胞的获得,具体步骤如下:The specific steps for obtaining pig skeletal muscle satellite cells are as follows:
宰杀刚出生的小猪,快速采取每一个体的半键肌以及背肌,并立即置于Hanks液中、包装后做下一步处理;Slaughter the newborn piglets, quickly take the half-bond muscles and back muscles of each individual, and immediately put them in Hanks solution, pack them and do the next step;
净台中切取所需骨骼肌,用含有1%双抗的PBS清洗,尽可能去除脂肪、肌键、肌膜等结缔组织;Cut out the required skeletal muscle in the clean bench, wash with PBS containing 1% double antibody, and remove connective tissues such as fat, muscle bonds, and sarcolemma as much as possible;
剪碎至2mm3左右移入离心管后PBS反复吹打3次,自然沉降5分钟,弃上清液;加入0.2%胶原酶,37℃水浴消化50min,每隔5min震荡一次,结束后用PBS清洗三次,于 1000r/min转速下离心10min,弃上清液;然后用适量的0.25%胰蛋白酶于37%水浴消化 20min,每隔5min震荡一次,消化结束后立即加入等体积培养基(DMEM/F12+20%FBS+ 1%双抗)终止消化,依次经过100目、200目和400目细胞筛过滤,将过滤后的悬液于1000r/min 转速下离心10min,弃上清液,沉淀后的细胞用生长培养基接种于细胞培养皿中;将消化后所得细胞悬液加入培养皿中,于37℃、5%CO2细胞培养箱中培养(所用每100ml培养基成分为:80%DMEM/F12、20%FBS、0.5%CEE、1%GlutaMax,1%NEAA,1%双抗,2.5ul bFGF) 2h后,然后缓慢吸出培养液并加到新的预铺多聚赖氨酸的培养皿中,12h后吸出培养液,再加到新的培养瓶中,即可得到纯的骨骼肌卫星细胞,其形态如图1所示。Cut into pieces to about 2 mm3 and transfer to a centrifuge tube, blow and beat with PBS 3 times, settle naturally for 5 minutes, and discard the supernatant; add 0.2% collagenase, digest in a 37°C water bath for 50 minutes, shake once every 5 minutes, and wash with PBS three times after the end. Centrifuge at 1000r/min for 10min, discard the supernatant; then digest with an appropriate amount of 0.25% trypsin in a 37% water bath for 20min, shake once every 5min, and immediately add an equal volume of medium (DMEM/F12+20 %FBS + 1% double antibody) to stop the digestion, filter through 100-mesh, 200-mesh and 400-mesh cell sieves successively, centrifuge the filtered suspension at 1000r/min for 10min, discard the supernatant, and use the precipitated cells for growth Culture medium is inoculated in cell culture dish; Gained cell suspension is added in culture dish after digestion, at 37 ℃, 5% CO 2Cultivate in cell culture box (used every 100ml medium composition is: 80%DMEM/F12, 20 %FBS, 0.5% CEE, 1% GlutaMax, 1% NEAA, 1% double antibody, 2.5ul bFGF) after 2h, then slowly suck out the culture solution and add it to a new pre-coated poly-lysine Petri dish, 12h Afterwards, the culture solution was sucked out, and then added to a new culture bottle to obtain pure skeletal muscle satellite cells, the morphology of which is shown in Figure 1.
由图1可知,骨骼肌卫星细胞呈长梭形。It can be seen from Figure 1 that skeletal muscle satellite cells are long spindle-shaped.
实施例2Example 2
将实施例1得到的纯的骨骼肌卫星细胞在4wt%多聚甲醛细胞固定液中固定15分钟后,用0.25%TritonX-100进行细胞通透,随后用PBS漂洗3次,再加入3wt%BSA进行封闭1h,加入一抗PAX-7,4℃中孵育过夜,吸去一抗PAX-7后用PBST洗三遍,加入荧光二抗,避光孵育一小时后再倒置荧光显微镜下观察,如图2所示。After the pure skeletal muscle satellite cells obtained in Example 1 were fixed in 4wt% paraformaldehyde cell fixative for 15 minutes, the cells were permeabilized with 0.25% TritonX-100, followed by rinsing with PBS for 3 times, and then adding 3wt% BSA Block for 1 hour, add primary antibody PAX-7, incubate overnight at 4°C, absorb primary antibody PAX-7, wash with PBST three times, add fluorescent secondary antibody, incubate for one hour in the dark, then observe under an inverted fluorescence microscope, as shown Figure 2 shows.
由图2可知,PAX-7呈绿色荧光阳性表达,细胞核呈蓝色。由此证明,实施例1获得的细胞确为骨骼肌卫星细胞。It can be seen from Figure 2 that PAX-7 was positively expressed in green fluorescence, and the nuclei were in blue. This proves that the cells obtained in Example 1 are indeed skeletal muscle satellite cells.
实施例3Example 3
诱导猪骨骼肌卫星细胞生脂,具体步骤如下:To induce adipogenesis of porcine skeletal muscle satellite cells, the specific steps are as follows:
A.从刚出生1-5d的仔猪背肌中采集骨骼肌卫星细胞,经过差速贴壁纯化细胞,纯化后的骨骼肌卫星细胞待贴壁汇合到60%-70%时,进行生脂诱导;A. Collect skeletal muscle satellite cells from the dorsal muscle of piglets just born 1-5 days old, and purify the cells through differential adhesion. After the purified skeletal muscle satellite cells are adhered to 60%-70% of the confluence, they will be induced by lipogenesis ;
B、诱导分化的第1-2d,向DMEM/F12基础培养基中添加1μmol/L地塞米松、5μg/mL胰岛素、0.5mmol/L 3-异丁基-1-甲基黄嘌呤和1%双抗,培养2d;B. On the 1-2d day of induction of differentiation, add 1 μmol/L dexamethasone, 5 μg/mL insulin, 0.5 mmol/L 3-isobutyl-1-methylxanthine and 1% to DMEM/F12 basal medium Double antibody, cultivated for 2 days;
C、诱导分化的第3-4d,向DMEM/F12基础培养基中添加5μg/mL胰岛素、10uM罗格列酮和1%双抗,培养2d;C. On the 3rd-4th day of induction of differentiation, add 5 μg/mL insulin, 10uM rosiglitazone and 1% double antibody to the DMEM/F12 basal medium, and culture for 2 days;
D、诱导分化的第5-6d,向DMEM/F12基础培养基中添加1μmol/L地塞米松、5μg/mL胰岛素、0.5mmol/L 3-异丁基-1-甲基黄嘌呤和1%双抗,培养2d;D. On day 5-6 of induction of differentiation, add 1 μmol/L dexamethasone, 5 μg/mL insulin, 0.5 mmol/L 3-isobutyl-1-methylxanthine and 1% to DMEM/F12 basal medium Double antibody, cultivated for 2 days;
E、诱导分化的第7-8d,向DMEM/F12基础培养基中添加5μg/mL胰岛素、10uM罗格列酮和1%双抗,培养2d;E. On the 7th-8th day of induction of differentiation, add 5 μg/mL insulin, 10 uM rosiglitazone and 1% double antibody to the DMEM/F12 basal medium, and culture for 2 days;
F、诱导分化的第9-10d,向DMEM/F12基础培养基中添加10mM葡萄糖和1%双抗,培养2d;F. On the 9th-10th day of induction of differentiation, add 10 mM glucose and 1% double antibody to the DMEM/F12 basal medium, and culture for 2 days;
所述百分比均指体积百分比。The stated percentages all refer to volume percentages.
实施例4Example 4
将实施例3细胞产生的脂滴根据油红O染色试剂盒使用说明书进行油红染色试验,结果如图3-6所示;其中,图3为2d油红O染色结果图;图4为4d油红O染色结果图;图5 为6d油红O染色结果图;图6为8d油红O染色结果图;图7为10d油红O染色结果图。The lipid droplets produced by the cells of Example 3 were subjected to an oil red staining test according to the instruction manual of the oil red O staining kit, and the results are shown in Figures 3-6; among them, Figure 3 is the result of Oil Red O staining in 2d; Figure 4 is the result of 4d Oil red O staining results; Figure 5 is the 6d oil red O staining results; Figure 6 is the 8d oil red O staining results; Figure 7 is the 10d oil red O staining results.
由图3-7可知,猪骨骼肌卫星细胞生脂效果明显。It can be seen from Figure 3-7 that the pig skeletal muscle satellite cells have an obvious lipogenic effect.
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。In addition, it should be understood that although this specification is described according to implementation modes, not each implementation mode only includes an independent technical solution, and this description in the specification is only for clarity, and those skilled in the art should take the specification as a whole , the technical solutions in the various embodiments can also be properly combined to form other implementations that can be understood by those skilled in the art.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011076142.8A CN114317417B (en) | 2020-10-10 | 2020-10-10 | Method for inducing skeletal muscle satellite cells to generate lipid droplets |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011076142.8A CN114317417B (en) | 2020-10-10 | 2020-10-10 | Method for inducing skeletal muscle satellite cells to generate lipid droplets |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114317417A CN114317417A (en) | 2022-04-12 |
CN114317417B true CN114317417B (en) | 2023-05-12 |
Family
ID=81032200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011076142.8A Active CN114317417B (en) | 2020-10-10 | 2020-10-10 | Method for inducing skeletal muscle satellite cells to generate lipid droplets |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114317417B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101886060A (en) * | 2010-07-20 | 2010-11-17 | 东北农业大学 | Method for Isolation, Culture and Differentiation Induction of Bovine Muscle Satellite Cells in Vitro |
CN104388435A (en) * | 2014-10-28 | 2015-03-04 | 四川农业大学 | Construction and application of goat adiponectin gene eukaryotic expression vector |
CN106754664A (en) * | 2016-12-26 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | It is a kind of to induce the culture medium that break up into fat of Skeletal Muscle derived stem cells and its apply and into fat differentiation method |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9976140B2 (en) * | 2013-06-14 | 2018-05-22 | Joslin Diabetes Center, Inc. | Microrna and uses in brown fat differentiation |
-
2020
- 2020-10-10 CN CN202011076142.8A patent/CN114317417B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101886060A (en) * | 2010-07-20 | 2010-11-17 | 东北农业大学 | Method for Isolation, Culture and Differentiation Induction of Bovine Muscle Satellite Cells in Vitro |
CN104388435A (en) * | 2014-10-28 | 2015-03-04 | 四川农业大学 | Construction and application of goat adiponectin gene eukaryotic expression vector |
CN106754664A (en) * | 2016-12-26 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | It is a kind of to induce the culture medium that break up into fat of Skeletal Muscle derived stem cells and its apply and into fat differentiation method |
Non-Patent Citations (8)
Title |
---|
De Coppi P 等."Rosiglitazone modifies the adipogenic potential of human muscle satellite cells".《DIABETOLOGIA》.2006,第49卷(第8期),1962-1973 . * |
Deng B 等."Functional analysis of pig myostatin gene promoter with some adipogenesis- and myogenesis-related factors".《MOLECULAR AND CELLULAR BIOCHEMISTRY》.2012,第363卷(第1-2期),291-299. * |
Itoigawa Y 等."Hypoxia induces adipogenic differentitation of myoblastic cell lines".《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》.2010,第399卷(第4期),721-726. * |
Ninomiya Y等."Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived nnesenchymal stem cells".《BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS》.2010,第394卷(第2期),303-308. * |
Wu H 等."In vitro culture and induced differentiation of sheep skeletal muscle satellite cells".《Cell Biol Int》.2012,第36卷(第6期),579-587. * |
刘扬."Hedgehog信号通路调控牛肌卫星细胞增殖和分化的研究".《中国博士学位论文全文数据库 农业科技辑》.2015,(第2期),D050-14. * |
秦本源 等."猪骨骼肌卫星细胞分离培养、鉴定及其生物学特性".《中国农业科学》.2020,第53卷(第8期),摘要,第1667页右栏第3段. * |
韩海银."猪肌内与皮下脂肪细胞胰岛素信号和脂质代谢比较及肌肉条件培养基对其调控机制的研究".《中国博士学位论文全文数据库 农业科技辑》.2020,(第8期),D050-23. * |
Also Published As
Publication number | Publication date |
---|---|
CN114317417A (en) | 2022-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3388512B1 (en) | Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord | |
US20090124007A1 (en) | Method for the Simultaneous Primary-Isolation and Expansion of Endothelial Stem/Progenitor Cell and Mesenchymal Stem Cell Derived From Mammal Including Human Umbilical Cord | |
CN106906182A (en) | A serum-free medium for mesenchymal stem cells | |
AU2013281596A1 (en) | High-concentration stem cell production method | |
CN104212763B (en) | A kind of separation of interstitial tissue[of testis] stem cell, cultural method and application thereof | |
CN101818127A (en) | Method for separating and culturing mouse primitive spermatogonia | |
KR102453925B1 (en) | Manufacturing method of in vitro meat using satellite cell of jeju black cattle | |
CN102191221A (en) | Neural stem cell capable of self-renewing, preparation method and application thereof | |
CN103013917A (en) | Method for inducing human amniotic mesenchymal stem cells to differentiate into neuron-like cells | |
JP2010252778A (en) | Method for separating dental pulp-derived mesenchymal stem cell, separated stem cell and differentiation to hepatocyte lineage using them | |
CN114317417B (en) | Method for inducing skeletal muscle satellite cells to generate lipid droplets | |
CN102021143B (en) | Pretreatment method for improving migration capability of mesenchymal stem cells | |
CN104212767B (en) | A method for isolating, culturing and using testicular mesenchymal stem cells expressing nestin | |
Yamasaki et al. | Long-term serial cultivation of mouse induced pluripotent stem cells in serum-free and feeder-free defined medium | |
CN113088482B (en) | Method for separating and culturing rumen epithelial cells of calves | |
CN101709289A (en) | Method for inducing transformation of totipotent stem cells into mesenchymal stem cells | |
CN104403988B (en) | A kind of inducing mouse embryonic stem cell breaks up the method for inner ear hair cells | |
CN112080464B (en) | A kind of canine umbilical cord-derived mesenchymal stem cell culture medium and culture method | |
CN104388381A (en) | Method for induced differentiation of inner ear hair cells by virtue of human mesenchymal stem cells | |
CN113388576A (en) | Rat vascular smooth muscle cell culture medium and application thereof | |
CN104630140A (en) | Isolation and culture method of placenta mesenchyma precursor stem cells | |
CN1920010A (en) | Method of separating multipotent adult progenitor cells from umbilical cord blood | |
CN103205394A (en) | Culture medium and application thereof | |
JP6721504B2 (en) | Process for producing pluripotent stem and progenitor cells | |
WO2024088255A1 (en) | Spontaneously immortalized porcine myogenic stem cell line and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |